Skip to content

Study on the rehabilitation effect of tDCS on cancer-related pain and its central regulatory mechanism

Study on the rehabilitation effect of tDCS on cancer-related pain and its central regulatory mechanism

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400086387
Enrollment
Unknown
Registered
2024-07-01
Start date
2024-07-05
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer-related pain

Interventions

experimental group:M1-tDCS anode true stimulation, 5 times a week, 20 minutes each time, for a total of 3 weeks
control group:M1-tDCS sham stimulation, only 20 minutes of stimulation for the first and last 30 seconds of stimulation, no actual effect, 5 times a week, 20 minutes each time, for a total of 3 weeks

Sponsors

The Sixth Affiliated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Be between the ages of 18-70; (2) Diagnosed with cancer requiring surgery and/or radiotherapy or chemotherapy; (3) Chief complainant of cancer-related pain for not less than 6 months; (4) Pain symptom severity score (Visual Analogue Score VAS) greater than or equal to 4 points.

Exclusion criteria

Exclusion criteria: (1) Combined with other chronic pain diseases such as fibromyalgia, low back pain, osteoarthritis pain, etc.; (2) Serious underlying diseases including gout, diabetes, coronary heart disease, hypertension, chronic kidney disease, progressive bleeding, cancer, central nervous system diseases such as stroke, cerebral hemorrhage, spinal cord injury, etc.; (3) Concomitant mental illness or abnormal mental status; (4) the presence of cognitive dysfunction; (5) There are contraindications to MRI examination, such as metal implants, dentures, pacemakers, etc.; (6) Received analgesic drug injection or analgesic pump implantation within the past 1 month; (7) Extremely severe cancer pain requires long-term dependence on morphine drugs, etc.

Design outcomes

Primary

MeasureTime frame
Pain intensity;

Secondary

MeasureTime frame
Quantitative testing of central sensitization;Central Sensitization Scale;Quality of life assessment;Multimodal MRI brain imaging system;

Countries

China

Contacts

Public ContactBeibei Feng

Department of Rehabilitation Medicine, The Sixth Affiliated Hospital of Sun Yat-sen University

fengbb@mail.sysu.edu.cn+86 131 4366 3961

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026